Nordea Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,211
| Closed | -$628K | – | 928 |
|
|
2024
Q1 | $628K | Sell |
5,211
-915
| -15% | -$110K | ﹤0.01% | 881 |
|
|
2023
Q4 | $744K | Sell |
6,126
-440
| -7% | -$53.4K | ﹤0.01% | 862 |
|
|
2023
Q3 | $858K | Sell |
6,566
-348
| -5% | -$45.5K | ﹤0.01% | 838 |
|
|
2023
Q2 | $859K | Hold |
6,914
| – | – | ﹤0.01% | 839 |
|
|
2023
Q1 | $1M | Sell |
6,914
-595
| -8% | -$86.1K | ﹤0.01% | 789 |
|
|
2022
Q4 | $1.19M | Buy |
7,509
+1,138
| +18% | +$180K | ﹤0.01% | 742 |
|
|
2022
Q3 | $858K | Sell |
6,371
-3,585
| -36% | -$483K | ﹤0.01% | 801 |
|
|
2022
Q2 | $1.56M | Buy |
9,956
+1,154
| +13% | +$180K | ﹤0.01% | 728 |
|
|
2022
Q1 | $1.39M | Hold |
8,802
| – | – | ﹤0.01% | 750 |
|
|
2021
Q4 | $1.14M | Hold |
8,802
| – | – | ﹤0.01% | 788 |
|
|
2021
Q3 | $1.15M | Hold |
8,802
| – | – | ﹤0.01% | 786 |
|
|
2021
Q2 | $1.56M | Sell |
8,802
-13,393
| -60% | -$2.38M | ﹤0.01% | 716 |
|
|
2021
Q1 | $3.69M | Sell |
22,195
-2,363
| -10% | -$393K | 0.01% | 624 |
|
|
2020
Q4 | $4.05M | Hold |
24,558
| – | – | 0.01% | 610 |
|
|
2020
Q3 | $3.47M | Sell |
24,558
-24,558
| -50% | -$3.47M | 0.01% | 583 |
|
|
2020
Q2 | $5.34M | Buy |
49,116
+20,831
| +74% | +$2.27M | 0.01% | 604 |
|
|
2020
Q1 | $2.84M | Hold |
28,285
| – | – | 0.01% | 582 |
|
|
2019
Q4 | $4.21M | Hold |
28,285
| – | – | 0.01% | 599 |
|
|
2019
Q3 | $3.6M | Buy |
28,285
+522
| +2% | +$66.4K | 0.01% | 631 |
|
|
2019
Q2 | $3.96M | Sell |
27,763
-15,600
| -36% | -$2.23M | 0.01% | 597 |
|
|
2019
Q1 | $6.2M | Sell |
43,363
-1,596
| -4% | -$228K | 0.01% | 487 |
|
|
2018
Q4 | $5.57M | Buy |
44,959
+3,400
| +8% | +$421K | 0.01% | 472 |
|
|
2018
Q3 | $6.99M | Buy |
+41,559
| New | +$6.99M | 0.01% | 469 |
|